A drug developed at UB to treat FOXG1 syndrome has been cleared by the U.S. Food and Drug Administration to begin clinical trials. The agency approved an Investigational New Drug (IND) application for ...
Soo-Kyung Lee, a neurodevelopmental biologist from the State University of New York at Buffalo, built her career studying transcription factors important for brain development and understanding how ...
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today a collaboration with the FOXG1 Research Foundation (FRF) highlighting the patient ...
FOXG1 syndrome is a complex neurodevelopmental condition arising from mutations in the FOXG1 gene, a critical transcription factor that regulates forebrain development. The syndrome is characterised ...
BUFFALO, N.Y. — A viral gene therapy developed by University at Buffalo researchers has reversed some brain abnormalities in infant mice with FOXG1 syndrome, a significant step toward one day treating ...
Researchers in Taiwan and Belgium developed a lab-based diagnostic workflow that could help doctors predict the severity of a rare childhood brain disorder called FOXG1 syndrome (a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results